Endra Life Sciences Inc (NDRA): Probably not until after CE approval unl...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	27
Posts	12075
Boards Moderated	0
Alias Born	01/02/2003

dndodd

Re: bert1977 post# 153

Monday, 12/09/2019 11:09:35 AM

Monday, December 09, 2019 11:09:35 AM

Probably not until after CE approval unless someone like a drug company or GE commits to a pre approval unit. Or issue a PO for once approval is attained.

"The Investors's Chief Problem--and even his worst enemy--is likely to be himself"
---Benjamin Graham

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent NDRA News

Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:10:30 PM
ENDRA Life Sciences Announces Reverse Stock Split • Business Wire • 08/16/2024 12:00:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2024 09:00:03 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:06:44 PM
ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024 • Business Wire • 08/13/2024 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 01:24:59 PM
ENDRA Life Sciences Announces Leadership Changes • Business Wire • 08/13/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 12:02:42 PM
ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14 • Business Wire • 08/07/2024 12:00:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/17/2024 08:16:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:16:45 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/14/2024 08:01:26 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/14/2024 12:00:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 12:00:40 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/05/2024 04:15:12 AM
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering • Business Wire • 06/04/2024 01:21:00 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/31/2024 08:21:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 12:05:32 PM
ENDRA Provides Update Following In-person Meeting with FDA • Business Wire • 05/20/2024 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:26:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:17:00 PM
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update • Business Wire • 05/14/2024 08:05:00 PM

More NDRA News

InvestorsHub NewsWire

FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM

Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM

Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM

HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM

PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM

VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover